Scientists from Brighton and Sussex Medical School have shown that the coronavirus, which causes COVID-19, affects the blood coagulation and anticoagulation system. Therefore, one of the most dangerous complications of this disease is thrombosis. The study was published in the Clinical Medicine Journal, Medical Xpress reports.
Of the 274 hospitalized patients, 7.7% were diagnosed with venous thromboembolism. The danger of this condition is that blood clots block microcirculation in the most important organs. First of all, in the lungs. This type of thromboembolism was detected in 76.2% of cases. In addition, increased blood clotting affects the liver and kidneys. According to scientists, it is possible to identify people at an increased risk of blood clots among those infected with COVID-19 using a blood test for D-dimer.
Scientists have identified a group of people immune to coronavirus
“Identifying patients at high risk of developing or already developing venous thromboembolism in COVID-19 is very important for two reasons. First, this condition is associated with the risk of death. Secondly, it can be treated with anticoagulants (blood-thinning drugs. - RBC Style) ", - comments the lead author of the study, Dr. Chi Ezifula. Urgent clinical trials are now required to assess the value of anticoagulant treatment, the study said.
Recall that it was the separation of a blood clot that became the main cause of death of the first 79-year-old Moscow resident who died from coronavirus. This happened on March 19 - a week after the patient was hospitalized. Initially, doctors assumed that the woman died due to coronavirus pneumonia.
How to take a coronavirus antibody test and what it will tell you about.